These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

67 related items for PubMed ID: 3160926

  • 1. [Clinical study of immunosuppressives in cancer patients].
    Tanada M.
    Nihon Geka Gakkai Zasshi; 1985 May; 86(5):514-26. PubMed ID: 3160926
    [Abstract] [Full Text] [Related]

  • 2. Induction of suppressor cell activities in normal lymphocytes by sera from gastric cancer patients.
    Toge T, Tanada M, Yajima K, Kohno H, Itagaki E, Hattori T.
    Clin Exp Immunol; 1983 Oct; 54(1):80-6. PubMed ID: 6225584
    [Abstract] [Full Text] [Related]

  • 3. [Significance of human Tr cell in gastric cancer --with special reference to suppressor cell activity].
    Itagaki E, Toge T, Tanada M, Hamamoto S, Seto Y, Kohno H, Hattori T.
    Gan To Kagaku Ryoho; 1984 Jan; 11(1):123-9. PubMed ID: 6230053
    [Abstract] [Full Text] [Related]

  • 4. [Immune reactivities of lymphocytes from peripheral blood, regional lymph nodes and tumor-infiltrating lymphocytes in breast cancer].
    Hisamatsu K, Toge T, Yanagawa E, Hamada Y, Seto Y, Yamada H, Toi M, Hattori T.
    Gan To Kagaku Ryoho; 1986 Aug; 13(8):2555-61. PubMed ID: 2943228
    [Abstract] [Full Text] [Related]

  • 5. [Experimental and clinical studies on the significance of human T cells bearing IgG-Fc receptor (T gamma cells) in gastric cancer patients].
    Itagaki E.
    Nihon Geka Gakkai Zasshi; 1985 Oct; 86(10):1405-16. PubMed ID: 2934614
    [Abstract] [Full Text] [Related]

  • 6. [The relationship between serum immunosuppressive acidic protein (IAP) and cellular immunity in the patients with gastric cancer].
    Nakanishi K, Toge T, Hamamoto S, Tanada M, Itagaki E, Kohno H, Yanagawa E, Hattori T.
    Gan To Kagaku Ryoho; 1982 Oct; 9(10):1827-31. PubMed ID: 6223588
    [Abstract] [Full Text] [Related]

  • 7. [Analysis of suppressor cell activities in spleen cells from gastric cancer patients and the effect of splenectomy on prognosis of gastric cancer].
    Toge T, Hamamoto S, Itagaki E, Nakane H, Yajima K, Hattori T.
    Nihon Geka Gakkai Zasshi; 1983 Sep; 84(9):961-4. PubMed ID: 6233481
    [Abstract] [Full Text] [Related]

  • 8. Effect of BM 12 531 on in vitro induction of suppressor cells by concanavalin A in cancer patients and normal healthy donors.
    Somasundaram R, Advani SH, Shetye MR, Gangal SG.
    J Clin Lab Immunol; 1986 Jan; 19(1):43-7. PubMed ID: 2939248
    [Abstract] [Full Text] [Related]

  • 9. Increased number of suppressor T-cells and impaired IL-2 mediated T-cell function in peripheral blood of gastric cancer patients.
    Tsubono M, Nio Y, Shiraishi T, Morimoto H, Tseng CC, Kawabata K, Masai Y, Fukumoto M, Tobe T.
    J Clin Lab Immunol; 1990 Nov; 33(3):107-15. PubMed ID: 1966999
    [Abstract] [Full Text] [Related]

  • 10. Suppressor leukocytes in anergic patients with solid tumors.
    Bankhurst AD, Kauffman GR, Goodwin JS, Saiki JH, Saiers JH, Williams RC.
    J Clin Lab Immunol; 1980 May; 3(3):159-63. PubMed ID: 6448298
    [Abstract] [Full Text] [Related]

  • 11. Induction of suppressor T cells by anti-globoside antibodies in cancer sera.
    Noguchi R, Shinomiya N, Nagai K, Yata J.
    Jpn J Clin Oncol; 1983 Jun; 13(2):335-42. PubMed ID: 6224953
    [Abstract] [Full Text] [Related]

  • 12. Generation of suppressor cells for natural killer activity in cancer patients after surgery.
    Uchida A, Kolb R, Micksche M.
    J Natl Cancer Inst; 1982 May; 68(5):735-41. PubMed ID: 6461792
    [Abstract] [Full Text] [Related]

  • 13. Deficient concanavalin-A-induced suppressor cell activity in women with untreated breast cancer.
    Gupta S, Cunningham-Rundles S.
    J Clin Lab Immunol; 1982 Dec; 9(3):159-61. PubMed ID: 6220154
    [Abstract] [Full Text] [Related]

  • 14. Suppression of T-cell response in autologous mixed lymphocyte-tumor culture by large granular lymphocytes.
    Uchida A, Klein E.
    J Natl Cancer Inst; 1986 Mar; 76(3):389-98. PubMed ID: 2419621
    [Abstract] [Full Text] [Related]

  • 15. Suppressor cells and survival of patients with advanced gastric cancer.
    Zembala M, Mytar B, Ruggiero I, Uracz W, Popiela T, Czupryna A.
    J Natl Cancer Inst; 1983 Feb; 70(2):223-8. PubMed ID: 6218331
    [Abstract] [Full Text] [Related]

  • 16. The mechanisms of inhibition of human IL 2 production. II. PGE2 induction of suppressor T lymphocytes.
    Chouaib S, Chatenoud L, Klatzmann D, Fradelizi D.
    J Immunol; 1984 Apr; 132(4):1851-7. PubMed ID: 6230395
    [Abstract] [Full Text] [Related]

  • 17. Loss of suppressor T cell function and circulating immune complexes in chronic active liver diseases.
    Hotta R, Kuriki J, Kakumu S.
    Clin Exp Immunol; 1981 Nov; 46(2):375-81. PubMed ID: 6461458
    [Abstract] [Full Text] [Related]

  • 18. Tumor-induced senescent T cells with suppressor function: a potential form of tumor immune evasion.
    Montes CL, Chapoval AI, Nelson J, Orhue V, Zhang X, Schulze DH, Strome SE, Gastman BR.
    Cancer Res; 2008 Feb 01; 68(3):870-9. PubMed ID: 18245489
    [Abstract] [Full Text] [Related]

  • 19. [Basic and clinical study of adoptive immunotherapy using cytotoxic T lymphocyte (CTL) against cancers].
    Kitsukawa K.
    Gan To Kagaku Ryoho; 1989 Apr 01; 16(4 Pt 2-2):1448-54. PubMed ID: 2543306
    [Abstract] [Full Text] [Related]

  • 20. Role of the spleen in immunosuppression of gastric cancer: predominance of suppressor precursor and suppressor inducer T cells in the recirculating spleen cells.
    Toge T, Kuroi K, Kuninobu H, Yamaguchi Y, Kegoya Y, Baba N, Hattori T.
    Clin Exp Immunol; 1988 Dec 01; 74(3):409-12. PubMed ID: 2976622
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.